Global Anti-PD-1 Antibody Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-PD-1 Antibody Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-PD-1 Antibody by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-PD-1 Antibody by Country/Region, 2017, 2022 & 2028

2.2 Anti-PD-1 Antibody Segment by Type

2.2.1 Monoclonal

2.2.2 Polyclonal

2.3 Anti-PD-1 Antibody Sales by Type

2.3.1 Global Anti-PD-1 Antibody Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-PD-1 Antibody Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-PD-1 Antibody Sale Price by Type (2017-2022)

2.4 Anti-PD-1 Antibody Segment by Application

2.4.1 IHC-P

2.4.2 ICC/IF

2.4.3 WB

2.4.4 Flow Cytometry

2.4.5 ELISA

2.5 Anti-PD-1 Antibody Sales by Application

2.5.1 Global Anti-PD-1 Antibody Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-PD-1 Antibody Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-PD-1 Antibody Sale Price by Application (2017-2022)

3 Global Anti-PD-1 Antibody by Company

3.1 Global Anti-PD-1 Antibody Breakdown Data by Company

3.1.1 Global Anti-PD-1 Antibody Annual Sales by Company (2020-2022)

3.1.2 Global Anti-PD-1 Antibody Sales Market Share by Company (2020-2022)

3.2 Global Anti-PD-1 Antibody Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-PD-1 Antibody Revenue by Company (2020-2022)

3.2.2 Global Anti-PD-1 Antibody Revenue Market Share by Company (2020-2022)

3.3 Global Anti-PD-1 Antibody Sale Price by Company

3.4 Key Manufacturers Anti-PD-1 Antibody Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-PD-1 Antibody Product Location Distribution

3.4.2 Players Anti-PD-1 Antibody Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-PD-1 Antibody by Geographic Region

4.1 World Historic Anti-PD-1 Antibody Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-PD-1 Antibody Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-PD-1 Antibody Annual Revenue by Geographic Region

4.2 World Historic Anti-PD-1 Antibody Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-PD-1 Antibody Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-PD-1 Antibody Annual Revenue by Country/Region

4.3 Americas Anti-PD-1 Antibody Sales Growth

4.4 APAC Anti-PD-1 Antibody Sales Growth

4.5 Europe Anti-PD-1 Antibody Sales Growth

4.6 Middle East & Africa Anti-PD-1 Antibody Sales Growth

5 Americas

5.1 Americas Anti-PD-1 Antibody Sales by Country

5.1.1 Americas Anti-PD-1 Antibody Sales by Country (2017-2022)

5.1.2 Americas Anti-PD-1 Antibody Revenue by Country (2017-2022)

5.2 Americas Anti-PD-1 Antibody Sales by Type

5.3 Americas Anti-PD-1 Antibody Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-PD-1 Antibody Sales by Region

6.1.1 APAC Anti-PD-1 Antibody Sales by Region (2017-2022)

6.1.2 APAC Anti-PD-1 Antibody Revenue by Region (2017-2022)

6.2 APAC Anti-PD-1 Antibody Sales by Type

6.3 APAC Anti-PD-1 Antibody Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-PD-1 Antibody by Country

7.1.1 Europe Anti-PD-1 Antibody Sales by Country (2017-2022)

7.1.2 Europe Anti-PD-1 Antibody Revenue by Country (2017-2022)

7.2 Europe Anti-PD-1 Antibody Sales by Type

7.3 Europe Anti-PD-1 Antibody Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-PD-1 Antibody by Country

8.1.1 Middle East & Africa Anti-PD-1 Antibody Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-PD-1 Antibody Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-PD-1 Antibody Sales by Type

8.3 Middle East & Africa Anti-PD-1 Antibody Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-PD-1 Antibody

10.3 Manufacturing Process Analysis of Anti-PD-1 Antibody

10.4 Industry Chain Structure of Anti-PD-1 Antibody

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-PD-1 Antibody Distributors

11.3 Anti-PD-1 Antibody Customer

12 World Forecast Review for Anti-PD-1 Antibody by Geographic Region

12.1 Global Anti-PD-1 Antibody Market Size Forecast by Region

12.1.1 Global Anti-PD-1 Antibody Forecast by Region (2023-2028)

12.1.2 Global Anti-PD-1 Antibody Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-PD-1 Antibody Forecast by Type

12.7 Global Anti-PD-1 Antibody Forecast by Application

13 Key Players Analysis

13.1 Bio X Cell

13.1.1 Bio X Cell Company Information

13.1.2 Bio X Cell Anti-PD-1 Antibody Product Offered

13.1.3 Bio X Cell Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bio X Cell Main Business Overview

13.1.5 Bio X Cell Latest Developments

13.2 Thermo Fisher

13.2.1 Thermo Fisher Company Information

13.2.2 Thermo Fisher Anti-PD-1 Antibody Product Offered

13.2.3 Thermo Fisher Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Thermo Fisher Main Business Overview

13.2.5 Thermo Fisher Latest Developments

13.3 InvivoGen

13.3.1 InvivoGen Company Information

13.3.2 InvivoGen Anti-PD-1 Antibody Product Offered

13.3.3 InvivoGen Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 InvivoGen Main Business Overview

13.3.5 InvivoGen Latest Developments

13.4 BioVision Inc

13.4.1 BioVision Inc Company Information

13.4.2 BioVision Inc Anti-PD-1 Antibody Product Offered

13.4.3 BioVision Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 BioVision Inc Main Business Overview

13.4.5 BioVision Inc Latest Developments

13.5 Abcam

13.5.1 Abcam Company Information

13.5.2 Abcam Anti-PD-1 Antibody Product Offered

13.5.3 Abcam Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Abcam Main Business Overview

13.5.5 Abcam Latest Developments

13.6 Bristol-Myers Squibb (BMS)

13.6.1 Bristol-Myers Squibb (BMS) Company Information

13.6.2 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Offered

13.6.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bristol-Myers Squibb (BMS) Main Business Overview

13.6.5 Bristol-Myers Squibb (BMS) Latest Developments

13.7 Merck

13.7.1 Merck Company Information

13.7.2 Merck Anti-PD-1 Antibody Product Offered

13.7.3 Merck Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck Main Business Overview

13.7.5 Merck Latest Developments

13.8 Ono Pharmaceutical Co., Ltd

13.8.1 Ono Pharmaceutical Co., Ltd Company Information

13.8.2 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Offered

13.8.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Ono Pharmaceutical Co., Ltd Main Business Overview

13.8.5 Ono Pharmaceutical Co., Ltd Latest Developments

13.9 Lilly

13.9.1 Lilly Company Information

13.9.2 Lilly Anti-PD-1 Antibody Product Offered

13.9.3 Lilly Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Lilly Main Business Overview

13.9.5 Lilly Latest Developments

13.10 Chugai Pharmaceutical Co., Ltd

13.10.1 Chugai Pharmaceutical Co., Ltd Company Information

13.10.2 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Offered

13.10.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Chugai Pharmaceutical Co., Ltd Main Business Overview

13.10.5 Chugai Pharmaceutical Co., Ltd Latest Developments

13.11 BeiGene

13.11.1 BeiGene Company Information

13.11.2 BeiGene Anti-PD-1 Antibody Product Offered

13.11.3 BeiGene Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 BeiGene Main Business Overview

13.11.5 BeiGene Latest Developments

13.12 Abbvie

13.12.1 Abbvie Company Information

13.12.2 Abbvie Anti-PD-1 Antibody Product Offered

13.12.3 Abbvie Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Abbvie Main Business Overview

13.12.5 Abbvie Latest Developments

13.13 TG Therapeutics, Inc

13.13.1 TG Therapeutics, Inc Company Information

13.13.2 TG Therapeutics, Inc Anti-PD-1 Antibody Product Offered

13.13.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 TG Therapeutics, Inc Main Business Overview

13.13.5 TG Therapeutics, Inc Latest Developments

13.14 Novartis

13.14.1 Novartis Company Information

13.14.2 Novartis Anti-PD-1 Antibody Product Offered

13.14.3 Novartis Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Novartis Main Business Overview

13.14.5 Novartis Latest Developments

13.15 Arcus Biosciences

13.15.1 Arcus Biosciences Company Information

13.15.2 Arcus Biosciences Anti-PD-1 Antibody Product Offered

13.15.3 Arcus Biosciences Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Arcus Biosciences Main Business Overview

13.15.5 Arcus Biosciences Latest Developments

13.16 Sino Biological Inc

13.16.1 Sino Biological Inc Company Information

13.16.2 Sino Biological Inc Anti-PD-1 Antibody Product Offered

13.16.3 Sino Biological Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Sino Biological Inc Main Business Overview

13.16.5 Sino Biological Inc Latest Developments

13.17 3SBio Inc

13.17.1 3SBio Inc Company Information

13.17.2 3SBio Inc Anti-PD-1 Antibody Product Offered

13.17.3 3SBio Inc Anti-PD-1 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 3SBio Inc Main Business Overview

13.17.5 3SBio Inc Latest Developments

14 Research Findings and Conclusion

Table 1. Anti-PD-1 Antibody Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-PD-1 Antibody Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Monoclonal

Table 4. Major Players of Polyclonal

Table 5. Global Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)

Table 6. Global Anti-PD-1 Antibody Sales Market Share by Type (2017-2022)

Table 7. Global Anti-PD-1 Antibody Revenue by Type (2017-2022) & ($ million)

Table 8. Global Anti-PD-1 Antibody Revenue Market Share by Type (2017-2022)

Table 9. Global Anti-PD-1 Antibody Sale Price by Type (2017-2022) & (USD/g)

Table 10. Global Anti-PD-1 Antibody Sales by Application (2017-2022) & (Kg)

Table 11. Global Anti-PD-1 Antibody Sales Market Share by Application (2017-2022)

Table 12. Global Anti-PD-1 Antibody Revenue by Application (2017-2022)

Table 13. Global Anti-PD-1 Antibody Revenue Market Share by Application (2017-2022)

Table 14. Global Anti-PD-1 Antibody Sale Price by Application (2017-2022) & (USD/g)

Table 15. Global Anti-PD-1 Antibody Sales by Company (2020-2022) & (Kg)

Table 16. Global Anti-PD-1 Antibody Sales Market Share by Company (2020-2022)

Table 17. Global Anti-PD-1 Antibody Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Anti-PD-1 Antibody Revenue Market Share by Company (2020-2022)

Table 19. Global Anti-PD-1 Antibody Sale Price by Company (2020-2022) & (USD/g)

Table 20. Key Manufacturers Anti-PD-1 Antibody Producing Area Distribution and Sales Area

Table 21. Players Anti-PD-1 Antibody Products Offered

Table 22. Anti-PD-1 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Anti-PD-1 Antibody Sales by Geographic Region (2017-2022) & (Kg)

Table 26. Global Anti-PD-1 Antibody Sales Market Share Geographic Region (2017-2022)

Table 27. Global Anti-PD-1 Antibody Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Anti-PD-1 Antibody Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Anti-PD-1 Antibody Sales by Country/Region (2017-2022) & (Kg)

Table 30. Global Anti-PD-1 Antibody Sales Market Share by Country/Region (2017-2022)

Table 31. Global Anti-PD-1 Antibody Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Anti-PD-1 Antibody Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Anti-PD-1 Antibody Sales by Country (2017-2022) & (Kg)

Table 34. Americas Anti-PD-1 Antibody Sales Market Share by Country (2017-2022)

Table 35. Americas Anti-PD-1 Antibody Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Anti-PD-1 Antibody Revenue Market Share by Country (2017-2022)

Table 37. Americas Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)

Table 38. Americas Anti-PD-1 Antibody Sales Market Share by Type (2017-2022)

Table 39. Americas Anti-PD-1 Antibody Sales by Application (2017-2022) & (Kg)

Table 40. Americas Anti-PD-1 Antibody Sales Market Share by Application (2017-2022)

Table 41. APAC Anti-PD-1 Antibody Sales by Region (2017-2022) & (Kg)

Table 42. APAC Anti-PD-1 Antibody Sales Market Share by Region (2017-2022)

Table 43. APAC Anti-PD-1 Antibody Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Anti-PD-1 Antibody Revenue Market Share by Region (2017-2022)

Table 45. APAC Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)

Table 46. APAC Anti-PD-1 Antibody Sales Market Share by Type (2017-2022)

Table 47. APAC Anti-PD-1 Antibody Sales by Application (2017-2022) & (Kg)

Table 48. APAC Anti-PD-1 Antibody Sales Market Share by Application (2017-2022)

Table 49. Europe Anti-PD-1 Antibody Sales by Country (2017-2022) & (Kg)

Table 50. Europe Anti-PD-1 Antibody Sales Market Share by Country (2017-2022)

Table 51. Europe Anti-PD-1 Antibody Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Anti-PD-1 Antibody Revenue Market Share by Country (2017-2022)

Table 53. Europe Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)

Table 54. Europe Anti-PD-1 Antibody Sales Market Share by Type (2017-2022)

Table 55. Europe Anti-PD-1 Antibody Sales by Application (2017-2022) & (Kg)

Table 56. Europe Anti-PD-1 Antibody Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Anti-PD-1 Antibody Sales by Country (2017-2022) & (Kg)

Table 58. Middle East & Africa Anti-PD-1 Antibody Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Anti-PD-1 Antibody Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Anti-PD-1 Antibody Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)

Table 62. Middle East & Africa Anti-PD-1 Antibody Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Anti-PD-1 Antibody Sales by Application (2017-2022) & (Kg)

Table 64. Middle East & Africa Anti-PD-1 Antibody Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Anti-PD-1 Antibody

Table 66. Key Market Challenges & Risks of Anti-PD-1 Antibody

Table 67. Key Industry Trends of Anti-PD-1 Antibody

Table 68. Anti-PD-1 Antibody Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Anti-PD-1 Antibody Distributors List

Table 71. Anti-PD-1 Antibody Customer List

Table 72. Global Anti-PD-1 Antibody Sales Forecast by Region (2023-2028) & (Kg)

Table 73. Global Anti-PD-1 Antibody Sales Market Forecast by Region

Table 74. Global Anti-PD-1 Antibody Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Anti-PD-1 Antibody Sales Forecast by Country (2023-2028) & (Kg)

Table 77. Americas Anti-PD-1 Antibody Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Anti-PD-1 Antibody Sales Forecast by Region (2023-2028) & (Kg)

Table 79. APAC Anti-PD-1 Antibody Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Anti-PD-1 Antibody Sales Forecast by Country (2023-2028) & (Kg)

Table 81. Europe Anti-PD-1 Antibody Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Anti-PD-1 Antibody Sales Forecast by Country (2023-2028) & (Kg)

Table 83. Middle East & Africa Anti-PD-1 Antibody Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Anti-PD-1 Antibody Sales Forecast by Type (2023-2028) & (Kg)

Table 85. Global Anti-PD-1 Antibody Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Anti-PD-1 Antibody Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Anti-PD-1 Antibody Sales Forecast by Application (2023-2028) & (Kg)

Table 89. Global Anti-PD-1 Antibody Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Anti-PD-1 Antibody Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Application (2023-2028)

Table 92. Bio X Cell Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 93. Bio X Cell Anti-PD-1 Antibody Product Offered

Table 94. Bio X Cell Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 95. Bio X Cell Main Business

Table 96. Bio X Cell Latest Developments

Table 97. Thermo Fisher Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 98. Thermo Fisher Anti-PD-1 Antibody Product Offered

Table 99. Thermo Fisher Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 100. Thermo Fisher Main Business

Table 101. Thermo Fisher Latest Developments

Table 102. InvivoGen Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 103. InvivoGen Anti-PD-1 Antibody Product Offered

Table 104. InvivoGen Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 105. InvivoGen Main Business

Table 106. InvivoGen Latest Developments

Table 107. BioVision Inc Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 108. BioVision Inc Anti-PD-1 Antibody Product Offered

Table 109. BioVision Inc Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 110. BioVision Inc Main Business

Table 111. BioVision Inc Latest Developments

Table 112. Abcam Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 113. Abcam Anti-PD-1 Antibody Product Offered

Table 114. Abcam Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 115. Abcam Main Business

Table 116. Abcam Latest Developments

Table 117. Bristol-Myers Squibb (BMS) Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 118. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Offered

Table 119. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 120. Bristol-Myers Squibb (BMS) Main Business

Table 121. Bristol-Myers Squibb (BMS) Latest Developments

Table 122. Merck Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 123. Merck Anti-PD-1 Antibody Product Offered

Table 124. Merck Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 125. Merck Main Business

Table 126. Merck Latest Developments

Table 127. Ono Pharmaceutical Co., Ltd Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 128. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Offered

Table 129. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 130. Ono Pharmaceutical Co., Ltd Main Business

Table 131. Ono Pharmaceutical Co., Ltd Latest Developments

Table 132. Lilly Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 133. Lilly Anti-PD-1 Antibody Product Offered

Table 134. Lilly Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 135. Lilly Main Business

Table 136. Lilly Latest Developments

Table 137. Chugai Pharmaceutical Co., Ltd Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 138. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Offered

Table 139. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 140. Chugai Pharmaceutical Co., Ltd Main Business

Table 141. Chugai Pharmaceutical Co., Ltd Latest Developments

Table 142. BeiGene Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 143. BeiGene Anti-PD-1 Antibody Product Offered

Table 144. BeiGene Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 145. BeiGene Main Business

Table 146. BeiGene Latest Developments

Table 147. Abbvie Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 148. Abbvie Anti-PD-1 Antibody Product Offered

Table 149. Abbvie Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 150. Abbvie Main Business

Table 151. Abbvie Latest Developments

Table 152. TG Therapeutics, Inc Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 153. TG Therapeutics, Inc Anti-PD-1 Antibody Product Offered

Table 154. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 155. TG Therapeutics, Inc Main Business

Table 156. TG Therapeutics, Inc Latest Developments

Table 157. Novartis Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 158. Novartis Anti-PD-1 Antibody Product Offered

Table 159. Novartis Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 160. Novartis Main Business

Table 161. Novartis Latest Developments

Table 162. Arcus Biosciences Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 163. Arcus Biosciences Anti-PD-1 Antibody Product Offered

Table 164. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 165. Arcus Biosciences Main Business

Table 166. Arcus Biosciences Latest Developments

Table 167. Sino Biological Inc Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 168. Sino Biological Inc Anti-PD-1 Antibody Product Offered

Table 169. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 170. Sino Biological Inc Main Business

Table 171. Sino Biological Inc Latest Developments

Table 172. 3SBio Inc Basic Information, Anti-PD-1 Antibody Manufacturing Base, Sales Area and Its Competitors

Table 173. 3SBio Inc Anti-PD-1 Antibody Product Offered

Table 174. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)

Table 175. 3SBio Inc Main Business

Table 176. 3SBio Inc Latest Developments

List of Figures

Figure 1. Picture of Anti-PD-1 Antibody

Figure 2. Anti-PD-1 Antibody Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-PD-1 Antibody Sales Growth Rate 2017-2028 (Kg)

Figure 7. Global Anti-PD-1 Antibody Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-PD-1 Antibody Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Monoclonal

Figure 10. Product Picture of Polyclonal

Figure 11. Global Anti-PD-1 Antibody Sales Market Share by Type in 2021

Figure 12. Global Anti-PD-1 Antibody Revenue Market Share by Type (2017-2022)

Figure 13. Anti-PD-1 Antibody Consumed in IHC-P

Figure 14. Global Anti-PD-1 Antibody Market: IHC-P (2017-2022) & (Kg)

Figure 15. Anti-PD-1 Antibody Consumed in ICC/IF

Figure 16. Global Anti-PD-1 Antibody Market: ICC/IF (2017-2022) & (Kg)

Figure 17. Anti-PD-1 Antibody Consumed in WB

Figure 18. Global Anti-PD-1 Antibody Market: WB (2017-2022) & (Kg)

Figure 19. Anti-PD-1 Antibody Consumed in Flow Cytometry

Figure 20. Global Anti-PD-1 Antibody Market: Flow Cytometry (2017-2022) & (Kg)

Figure 21. Anti-PD-1 Antibody Consumed in ELISA

Figure 22. Global Anti-PD-1 Antibody Market: ELISA (2017-2022) & (Kg)

Figure 23. Global Anti-PD-1 Antibody Sales Market Share by Application (2017-2022)

Figure 24. Global Anti-PD-1 Antibody Revenue Market Share by Application in 2021

Figure 25. Anti-PD-1 Antibody Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Anti-PD-1 Antibody Revenue Market Share by Company in 2021

Figure 27. Global Anti-PD-1 Antibody Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Anti-PD-1 Antibody Revenue Market Share by Geographic Region in 2021

Figure 29. Global Anti-PD-1 Antibody Sales Market Share by Region (2017-2022)

Figure 30. Global Anti-PD-1 Antibody Revenue Market Share by Country/Region in 2021

Figure 31. Americas Anti-PD-1 Antibody Sales 2017-2022 (Kg)

Figure 32. Americas Anti-PD-1 Antibody Revenue 2017-2022 ($ Millions)

Figure 33. APAC Anti-PD-1 Antibody Sales 2017-2022 (Kg)

Figure 34. APAC Anti-PD-1 Antibody Revenue 2017-2022 ($ Millions)

Figure 35. Europe Anti-PD-1 Antibody Sales 2017-2022 (Kg)

Figure 36. Europe Anti-PD-1 Antibody Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Anti-PD-1 Antibody Sales 2017-2022 (Kg)

Figure 38. Middle East & Africa Anti-PD-1 Antibody Revenue 2017-2022 ($ Millions)

Figure 39. Americas Anti-PD-1 Antibody Sales Market Share by Country in 2021

Figure 40. Americas Anti-PD-1 Antibody Revenue Market Share by Country in 2021

Figure 41. United States Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Anti-PD-1 Antibody Sales Market Share by Region in 2021

Figure 46. APAC Anti-PD-1 Antibody Revenue Market Share by Regions in 2021

Figure 47. China Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Anti-PD-1 Antibody Sales Market Share by Country in 2021

Figure 54. Europe Anti-PD-1 Antibody Revenue Market Share by Country in 2021

Figure 55. Germany Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Anti-PD-1 Antibody Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Anti-PD-1 Antibody Revenue Market Share by Country in 2021

Figure 62. Egypt Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Anti-PD-1 Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Anti-PD-1 Antibody in 2021

Figure 68. Manufacturing Process Analysis of Anti-PD-1 Antibody

Figure 69. Industry Chain Structure of Anti-PD-1 Antibody

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles